[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:vulvar-squamous-cell-carcinoma":3},{"name":4,"total":5,"trials":6,"biomarkers":23,"states":24},"Vulvar Squamous Cell Carcinoma",2,[7,15],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT05639972","E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers",[11],"Phase 1\u002FPhase 2","RECRUITING","2026-08-03T00:55:31.090736Z","2026-07-05T05:32:16.809101Z",{"nct_id":16,"title":17,"phases":18,"status":20,"updated_at":21,"content_modified":22},"NCT07672782","Tisotumab Vedotin in Squamous Cell Carcinoma of the Vulva",[19],"Phase 2","NOT_YET_RECRUITING","2026-08-03T01:02:30.018785Z","2026-07-05T03:45:20.432610Z",[],[]]